SCOTTSDALE, AZ / ACCESSWIRE / October 17, 2024 / CBD Life Sciences, Inc. (CBDL), a trailblazer in the rapidly expanding CBD and wellness industry, proudly announces a remarkable 1744.00% increase in ...

CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, ...

Groupon, with over 22.5 million active users and generating more than $550 million in annual revenue, now features CBDL's top-tier wellness products, unlocking massive e-commerce potential and ...

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain ...

Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly. SCOTTSDALE, AZ / ACCESSWIRE / December 18, 2024 / CBD Life Sciences Inc. (CBDL), a leading innovator in the ...

CBDL has already shown its ability to scale rapidly, with a 1405.46% revenue increase since February 2024, an astonishing achievement in a market that continues to expand. This growth is not by chance ...

The MarketWatch News Department was not involved in the creation of this content. With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking ...

SCOTTSDALE, AZ / ACCESSWIRE / October 31, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to ...

Company Reports 3.5 billion Share Reduction from the Authorization SCOTTSDALE, AZ / ACCESS Newswire / January 22, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD and wellness ...

This marks a significant East Coast retail expansion for CBDL, aligning the company with one of New York's top luxury spa chains while tapping into the booming nationwide demand for fast-acting ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...